Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
VRX

Valeant

$14.06

0.29 (2.11%)

14:05
09/20/17
09/20
14:05
09/20/17
14:05
Options
Valeant call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 02

    Oct

Monday
PRGO

Perrigo

$86.90

-1.97 (-2.22%)

, VRX

Valeant

$13.92

-0.07 (-0.50%)

08:49
09/18/17
09/18
08:49
09/18/17
08:49
Hot Stocks
Perrigo announces tentative FDA approval for generic version of Acanya gel »

Perrigo announced it has…

PRGO

Perrigo

$86.90

-1.97 (-2.22%)

VRX

Valeant

$13.92

-0.07 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 02

    Oct

VRX

Valeant

$13.92

-0.07 (-0.50%)

, MO

Altria Group

$62.39

0.11 (0.18%)

07:30
09/18/17
09/18
07:30
09/18/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

VRX

Valeant

$13.92

-0.07 (-0.50%)

MO

Altria Group

$62.39

0.11 (0.18%)

PEP

PepsiCo

$114.85

0.66 (0.58%)

CL

Colgate-Palmolive

$72.28

0.14 (0.19%)

PM

Philip Morris

$115.79

-0.94 (-0.81%)

SEAS

SeaWorld

$13.02

-0.2 (-1.51%)

XL

XL Group

$39.37

0.13 (0.33%)

ZGNX

Zogenix

$14.50

0.2 (1.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 02

    Oct

  • 04

    Oct

Friday
VRX

Valeant

$14.08

0.09 (0.64%)

10:40
09/15/17
09/15
10:40
09/15/17
10:40
Options
Far downside put buyer in Valeant »

Far downside put buyer in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 02

    Oct

Over a week ago
VRX

Valeant

09:21
09/05/17
09/05
09:21
09/05/17
09:21
Hot Stocks
Valeant's Ortho Dermatologics submits NDA for IDP-118 »

Ortho Dermatologics, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

IPXL

Impax

$17.95

-0.85 (-4.52%)

, VRX

Valeant

$13.49

0.2964 (2.25%)

12:55
08/31/17
08/31
12:55
08/31/17
12:55
Recommendations
Impax, Valeant, Dova Pharmaceuticals, Natures Sunshine Products analyst commentary at Raymond James »

Investors wrong to think…

IPXL

Impax

$17.95

-0.85 (-4.52%)

VRX

Valeant

$13.49

0.2964 (2.25%)

DOVA

Dova Pharmaceuticals

$24.75

-0.19 (-0.76%)

NATR

Natures Sunshine Products

$10.45

0.05 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

VRX

Valeant

$13.21

-1.02 (-7.17%)

13:09
08/29/17
08/29
13:09
08/29/17
13:09
Recommendations
Valeant analyst commentary at Cantor »

No fundamental reasons…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

VRX

Valeant

09:37
08/25/17
08/25
09:37
08/25/17
09:37
Periodicals
Lord Abbett stock fraud suit could be costly for Valeant, Bloomberg reports »

Lord Abbett & Co. has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

NICXF

NicOx

, VRX

Valeant

$14.42

0.07 (0.49%)

08:55
08/24/17
08/24
08:55
08/24/17
08:55
Conference/Events
Breaking Conference/Events news story on NicOx, Valeant »

FDA PDUFA Date for…

NICXF

NicOx

VRX

Valeant

$14.42

0.07 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

  • 11

    Sep

Over a month ago
VRX

Valeant

$14.15

0.25 (1.80%)

09:01
08/17/17
08/17
09:01
08/17/17
09:01
Recommendations
Valeant analyst commentary at Cantor »

Cantor says positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.